• Dermatology Risks Are Likely Different for JAK Inhibitors

    7 days ago - By Medscape

    Black box warnings for JAK inhibitors arise from rheumatoid arthritis studies, leading one expert to question the risk-benefit relevance to dermatologic diseases, particularly in younger patients.
    Medscape Medical News
    Read more ...